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Abstract
Background: We evaluated cytogenetic results occurring with first trimester pregnancy loss, and assessed the type
and frequency of chromosomal abnormalities after assisted reproductive treatment (ART) and compared them with
a control group. We also compared the rate of chromosomal abnormalities according to infertility causes in ICSI
group.
Methods: A retrospective cohort analysis was made of all patients who were referred to the Genetics Laboratory
of Fertility Center of CHA Gangnam Medical Center from 2005 to 2009 because of clinical abortion with a
subsequent dilation and evacuation (D&E) performed, and patients were grouped by type of conception as follows:
conventional IVF (in vitro fertilization) (n = 114), ICSI (intracytoplasmic sperm injection) (n = 140), and control
(natural conception or intrauterine insemination [IUI]) (n = 128). Statistical analysis was performed using SPSS
software.
Results: A total 406 specimens were referred to laboratory, ten abortuses were excluded, and in 14 cases, we did
not get any spontaneous metaphase, chromosomal constitutions of 382 specimens were successfully obtained
with conventional cytogenetic methods. Overall, 52.62% of the miscarriages were found to be cytogenetically
abnormal among all patients, the frequency was 48.4% in the control group, 54.3% of miscarriages after ICSI and
55.3% after conventional IVF (p = 0.503). The most prevalent abnormalities were autosomal trisomy, however, nine
(11.69%) sex chromosome aneuploidy were noted in the ICSI group vs. four (6.45%) and two (3.23%) cases in the
conventional IVF group and control group. We compared chromosomal abnormalities of miscarriages after ICSI
according to infertility factor. 55.71% underwent ICSI due to male factors, 44.29% due to non-male factors. ICSI
group having male factors showed significantly higher risk of chromosomal abnormalities than ICSI group having
non-male factors (65.8% vs. 34.2%, p = 0.009, odds ratio = 1.529, 95% CI = 1.092-2.141).
Conclusions: There is no increased risk of chromosomal abnormalities due to ART was found with the exception
of a greater number of sex chromosomal abnormalities in the ICSI group with male factor infertility. Therefore,
these alterations could be correlated with the underlying parental risk of abnormalities and not with the ICSI
procedure itself.
Background
Spontaneous abortion occurs in 15-20% of clinically
recognized gestations [1]. Genetic defects, especially
chromosomal abnormalities, are the most common
cause of spontaneous miscarriage during the first trime-
ster; indeed, chromosomal abnormalities occur in
approximately 60% of such cases [2]. It is unclear
whether pregnancies conceived through assisted repro-
ductive treatment (ART) are at an increased risk of
pregnancy loss compared with naturally conceived preg-
nancies, when accounting for maternal age and ART
procedures [3-5].
Few reports have examined pregnancy outcomes after
ART, and their results are inconclusive with regards to
the risk of miscarriage and aneuploidy. Intracytoplasmic
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incidence of aneuploidy and de novo sex chromosome
aberrations [6-8]. The additional risk of chromosomal
abnormalities for children conceived through ICSI is
approximately 1% above baseline, which is small but not
negligible, and a prenatal diagnosis may be offered [9].
Additionally, some studies f o u n dt h a tm a j o rc o n g e n i t a l
malformations were more frequent among ICSI off-
spring [10,11]. However, several studies report conflict-
ing results. Specifically, one study reported no increased
risk of congenital malformation or major developmental
delays associated with ICSI [12], and another showed
that couples that underwent ART did not exhibit
increased cytogenetic risks compared to a natural con-
ception group, and no significant difference was seen in
the incidence of chromosomal anomalies between ICSI
and in vitro fertilization (IVF) [13].
Few data from large sample sizes have been reported
on chromosomal abnormalities in miscarriages after
ART [13-15]. Thus, it remains controversial whether
ART results in an increased risk of chromosomal
abnormalities resulting in a first trimester miscarriage.
The aim of this study was to evaluate the types and fre-
quencies of chromosomal abnormalities occurring after
different types of ART and to compare the outcomes
for each ART group to those for a control group. More-
over, we compared the chromosomal abnormalities in
miscarriages after ICSI according to infertility factors.
Methods
A retrospective cohort analysis was conducted using
patients who were referred to the Genetics Laboratory
of the Fertility Center of CHA Gangnam Medical Center
from 2005 to 2009 following clinical abortion with sub-
sequent dilatation and evacuation (D&E). Patients were
grouped by the type of conception: conventional IVF,
ICSI, and controls, which included nonviable sponta-
neous pregnancies from infertile couples who had not
undergone ART and resulting from intrauterine insemi-
nation (IUI).
Except natural cycle protocol such as in vitro
maturation (IVM), most patients used either the GnRH
agonist (Lucrine®; Abbott, Cedex, France) long or
GnRH antagonist (Cetrotide®; Serono, Geneva, Switzer-
land) protocol for controlled ovarian stimulation
(COS) along with daily injections of rFSH (Gonal-F®;
Serono or Puregon®; Organon, Oss, The Netherlands).
And fertilization underwent, either by conventional
insemination or ICSI in IVF medium (Quinn’sA d v a n -
tage Medium®; SAGE BioPharma, Bedminster, NJ).
Fresh ejaculated sperm were evaluated by standard
andrological screening and World Health Organization
(WHO) values (volume, count, and motility); Kruger
morphologies were utilized to interpret semen quality
[16]. In addition, testicular sperm extraction (TESE)
was performed for patients with azoospermia or severe
oligoathenozoospermia (OAT).
Samples were obtained by D&E after spontaneous
abortion and collected in sterile containers containing
10 ml of RPMI-1640 with L-glutamine (Invitrogen, CA,
USA). In the Genetics Laboratory, trained technologists
dissected and selected the placental chorionic villi and
cultured them in BIO-AMP-2 complete medium (Biolo-
gical Industries Ltd., Haemek, Israel) at 37°C in a 5%
CO2 incubator. All procedures, including cell harvesting,
slide preparation, and staining, were conducted follow-
ing standard protocols [17]. At least 20 GTG-banded
metaphases were analyzed in each case.
Statistical analysis was performed using Statistical Pro-
gram for Social Science (SPSS 13.0, Chicago, IL) soft-
ware. Continuous variables were reported as the mean ±
standard deviation or as the median and range, depend-
ing on their distribution, with a normal distribution
defined using the one-way ANOVA test. Between-group
comparisons of normally distributed variables were
assessed using Student’s t-test. Categorical variables
were compared using the chi-square test. The signifi-
cance level for all analyses was set at p < 0.05. All data
are reported as means with their associated standard
deviations. Odds ratios and 95% confidence intervals
(CIs) are shown where appropriate.
The study protocol was approved by the Institutional
Review Board of CHA Gangnam Medical Center.
Results
A total of 406 specimens were assessed. Ten abortuses
were excluded for the following reasons: one was termi-
nated due to fetal anomalies during the second trime-
ster, two were diagnosed as hydatidiform moles, and
seven cases involved a parental chromosomal abnormal-
ity. Four cases were conceived by preimplantation
genetic diagnosis (PGD), while in fourteen out of 406
cases, cell culture failed because of absent or insufficient
villi, no growth, or bacterial contamination after incuba-
tion. The chromosomal constitutions of 382 specimens
were successfully obtained using conventional cytoge-
netic methods. Of these abortuses, 114 were derived
from conventional IVF, 140 were derived from ICSI, and
128 were derived from a control group.
The mean age of the female spouse was 35.23 (range
34.81-35.65 years). The mean age of the male spouse was
37.2 (range 36.72-37.69 years). The patients’ demo-
graphics, semen parameter results, basal hormonal profile,
and fetal gestational age at D&E are shown in Table 1.
The study population’s demographics were similar for
each group evaluated. However, as expected, paternal age,
previous pregnancy status, and semen parameters varied
significantly. Seminal volume did not differ in each group.
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significantly decreased in the ICSI group, whereas no dif-
ferences were seen between the control and conventional
IVF groups. The duration of infertility was 5.28 ± 5.96
years in the conventional IVF group and 4.89 ± 3.28 years
in the ICSI group (p = 0.521). In the conventional IVF
group, 56.1% (46/82) underwent the GnRH agonist long
protocol while 43.9% (36/82) underwent the GnRH
antagonist protocol for COS, whereas in the ICSI group,
the numbers were 46.94% (46/98) and 53.06% (52/98),
respectively. The mean number of retrieved oocytes,
mature oocytes, fertilized oocytes, embryos cultured on
day 3, and transferred embryos were not significantly dif-
ferent between the two groups. The mean number of
good-quality embryos or embryos transferred (ET), how-
ever, was 2.28 ± 1.01 in the conventional IVF group and
1.66 ± 1.12 in the ICSI group (p < 0.001).
Overall, 52.62% (201/382) of the miscarriages were
found to be cytogenetically abnormal among the
patients, with 48.44% (62/128) in the control group,
54.29% (76/140) after ICSI, and 55.26% (63/114) after
conventional IVF; there were no statistically significant
differences (p = 0.503). Specifically, 62.5% (55/88) of
miscarriages occurred after IVF-fresh cycle, 30.77% (8/
26) following IVF-thawing embryo transfer (TET),
56.44% (57/101) from ICSI-ejaculated sperm, 66.67% (6/
9) after ICSI-TESE, 60% (9/15) following ICSI-TET, and
26.67% (4/15) after IVM-ICSI (Table 2).
We compared the chromosomal abnormalities in mis-
carriages after ICSI according to infertility factors.
A total of 55.71% (78/140) underwent ICSI due to male
factors and 44.29% (62/140) due to non-male factors.
The ICSI group with male factors showed a significantly
increased risk of chromosomal abnormalities compared
to the ICSI group with non-male factors (65.79 vs.
34.21%, p = 0.009, odds ratio = 1.529, 95% CI = 1.092-
2.141) (Table 2).
We summarizes the distribution of cytogenetic results
for all of the pregnancies examined in the study. The
distribution of cytogenetic results was similar; however,
the incidence of sex chromosome aneuploidy was
11.69% (9/77) in the ICSI group vs. 6.45 (4/62) and
3.23% (2/62) in the conventional IVF and control
groups, respectively. If we add the one observed instance
of mosaic of sex chromosomes and two combined sex
and autosomal chromosome aneuploidies, the frequency
is increased by 15.58% (12/76) compared with non-ICSI
pregnancies, including conventional IVF and the control
g r o u p( 7 . 2 % ,9 / 1 2 5 )( p = 0.054). This, however, was not
statistically significant, although it might be due to the
small size. In the ICSI-TESE group, only autosomal tri-
somies were found. The most prevalent abnormalities
observed in first trimester pregnancy loss were autoso-
mal aneuploidy (79.6%; 160/201), similar to the ICSI
and conventional IVF and control groups (77.6, 77.8,
and 83.9%, respectively) (p = 0.604). Autosomal trisomy
Table 1 Patient demographics and laboratory findings
Control group
(n = 128)
Conventional
IVF group
(n = 114)
ICSI group
(n = 140)
p-value
Maternal age (yr) 34.52 ± 4.13 35.70 ± 3.97 35.49 ± 4.23 0.055
Paternal age (yr) 36.05 ± 4.34
a 37.43 ± 4.39
a,b 38.07 ± 5.40
b 0.002
Maternal BMI 21.13 ± 2.49 21.16 ± 3.04 21.73 ± 2.93 0.162
Semen analysis
Volume (ml) 2.91 ± 1.59 2.83 ± 1.18 2.57 ± 1.42 0.167
Count (x10
6/ml) 91.85 ± 43.72
a 93.62 ± 58.41
a 66.48 ± 66.50
b < 0.001
Morphology, strict 6.14 ± 2.36
a 6.68 ± 2.86
a 4.25 ± 3.57
b < 0.001
Motility 47.90 ± 15.46
a 48.56 ± 16.75
a 37.99 ± 21.11
b < 0.001
Hormonal profile
Basal FSH (u/ml) 7.17 ± 2.76 7.49 ± 5.08 7.28 ± 3.58 0.886
Basal LH (u/ml) 4.18 ± 4.01 3.06 ± 1.71 3.83 ± 3.08 0.127
Basal E2 (pg/ml) 28.25 ± 14.29 28.41 ± 21.74 30.44 ± 24.19 0.729
Fetal gestational age at D&E (days) 59.66 ± 8.23 61.00 ± 7.51 60.98 ± 7.77 0.300
Previous pregnancy status (n)
Parity 1.63 ± 1.47
a 1.32 ± 1.51
a,b 0.99 ± 1.18
b 0.001
Abortion 1.11 ± 1.21
a 0.61 ± 0.98
b 0.49 ± 0.66
b < 0.001
Yr: years, BMI: body mass index, D&E: dilatation and evacuation, FSH: follicular stimulating hormone, LH: luteinizing hormone, E2: estradiol, IVF: in vitro
fertilization, ICSI: intracytoplasmic insemination.
Values are mean ± SD.
Values with different superscripts are significantly different between
a and
b (p < 0.05).
Values with same superscripts are no significantly different between
a and
a or
b and
b.
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Page 3 of 6was the most common aneuploidy. In the ART group
(including conventional IVF and ICSI), trisomy 22
(24.24%, 24/99) was the most frequent anomaly, fol-
lowed by trisomy 16 (18.18%, 18/99); 15 (10.1%, 10/99);
4, 7, 8, and 21 (5.05%, 5/99 each); 20 (4.04%, 4/99); 3, 5,
12, 13, and 14 (3.03%, 3/99 each); 9 and 18 (2.02%, 2/99
each); and 2, 6, 10, and 11 (each was found in only one
case, 1.01%). In the control group, trisomy 16 and 22
(20%, 10/50 each) were the most common, followed by
trisomy 15 (12%, 6/50); 7 and 13 (8%, 4/50 each); and 2,
8, 10, 12, and 20 (4%, 2/50 each). Double aneuploidy
(including double autosomal aneuploidy and combined
autosomal and sex chromosome aneuploidy) occurred in
7.91% (11/139) of cases in the ART group and 4.84% (3/
62) of cases in the control group. Triple aneuploidy
occurred in one only of the ART cases. Polyploidy was
observed in 6.47% (9/139) of the ART cases and 9.68%
(6/62) of the control group cases.
Among the miscarriages with normal cytogenetic
results, 37.57% (68/181) were found to be normal male
and 62.43% (113/181) were found to be normal female
karyotypes. Among the miscarriages with abnormal
cytogenetic abnormalities, 55.22% (111/201) were found
to be abnormal female (without Y chromosome) while
44.78% (90/201) were found to be abnormal male karyo-
types (with Y chromosome).
Discussion
We found no significant increase in the occurrence of
chromosomal abnormalities in early pregnancy loss when
conception occurred through ART when compared with
the control group. However, sex chromosomal abnormal-
ities were increased among pregnancies resulting from
ICSI. Moreover, the ICSI group with male factors showed
a significantly increased risk of chromosomal abnormal-
ities compared to the ICSI group with non-male factors.
Concerns about ICSI-related chromosomal aberrations
were first raised in 1995 [18,19]. In’t Veld et al.[ 1 9 ]f i r s t
reported that 33% of ICSI pregnancies, in which all five
chromosomal abnormalities were sex chromosomal nat-
ure, identified by prenatal diagnosis. However, their
study included a selection bias, as it was based on a refer-
ral for advanced maternal age for prenatal diagnosis.
Additionally, the sample size was small and there was no
description of the parents’ genetic status. Nevertheless,
the relatively high risk of aneuploidy led to an expanded
study [18], which identified chromosomal anomalies in
1% of cases, and five of the six abnormalities reported
involved sex chromosomes. Several other investigators
followed up on these initial reports, with some subse-
quent reports suggesting an increased rate of chromoso-
mal aberrations in ICSI conception [6,8,9,20]. ICSI
bypasses natural selection mechanisms and may increase
first trimester aneuploidy rates [6]. Explanations for this
include (I) physical or biochemical disturbances of
the ooplasma or meiotic spindle, (II) injection of bio-
chemical contaminants, (III) injection of sperm-
associated exogenous DNA, (IV) injection of sperm
carrying a chromosomal anomaly, (V) transmission of
genetic defects that may be related to the underlying
male-factor infertility, (VI) male gametes with structural
defects, (VII) anomalies of sperm activating factors, (VIII)
potential for incorporating sperm mitochondrial DNA,
and (IX) female gamete anomalies [7]. However, other
studies of the incidence of aneuploidy in normal fetuses
and abortuses after IVF or ICSI produced conflicting
results [12,13]. Our study, which included a large sample
size, confirmed no significant difference for the total
abnormal karyotype rate in the abortuses between the
two groups (54.3% for ICSI and 55.3% for conventional
IVF), and there were no significant differences compared
with the control group (48.4%) (p = 0.503).
Table 2 Normal vs. abnormal karyotypes of miscarriages according to conception methods
Normal Abnormal Total
Male factor Non-male factor Total Male factor Non-male factor Total
Total ICSI 28 (43.75%) 36 (56.25%) 64 (45.71%) 50 (65.79%)
b 26 (34.21%)
b 76 (54.29%)
a 140
ICSI, ejaculated 19 25 44 (43.56%) 37 20 57 (56.44%) 101
ICSI, TESE 3 - 3 (33.33%) 6 - 6 (66.67%) 9
ICSI-TET 5 1 6 (40%) 5 4 9 (60%) 15
IVM 1 10 11 (73.33%) 2 2 4 (26.67%) 15
Total conventional IVF 51 (44.7%) 63 (55.26%)
a 114
IVF-fresh 33 55 88
IVF-TET 18 8 26
Control 66 (51.56%) 62 (48.44%)
a 128
Total 181 (47.38%) 201 (52.62%) 382
TESE: testicular sperm extraction, TET: thawing embryo transfer, IVM: in vitro maturation
ap = 0.503
bp = 0.009, OR = 1.529 (95% CI = 1.092 - 2.141)
Kim et al. BMC Medical Genetics 2010, 11:153
http://www.biomedcentral.com/1471-2350/11/153
Page 4 of 6We assessed the type and frequency of chromosomal
abnormalities following different ART treatments and
compared them with those following natural conception.
Among the normal cytogenetic results, a normal female
karyotype was found 1.7 times more frequently than a
normal male karyotype. However, the sex ratio among
abortuses with chromosomal anomalies did not differ,
similar to previous studies [7]. In particular, sex ratios
among the abnormal cytogenetic results were 0.8 in the
conventional IVF group, 0.85 in the ICSI group, and
0.77 in the control group. The sex ratio discrepancy
among the normal cytogenetic results may be due to
maternal cell contamination.
The most common abnormal karyotype encountered
was autosomal trisomy in all groups, and the frequency
was similar in each group. However, sex chromosome
aneuploidy was observed more frequently among preg-
nancies resulting from ICSI compared to conventional
IVF, in accordance with recent studies [7,15]. Several stu-
dies have documented a significant rise in the frequency
of sex chromosomal abnormalities in sperm from males
with abnormal spermatogenesis. Infertile men with a nor-
mal karyotype and abnormal spermatogenesis have been
shown to carry a significantly increased risk of producing
aneuploid spermatozoa, particularly for the sex chromo-
somes [12,21-23]. These studies are in accordance with
the increased incidence of sex chromosomal abnormal-
ities in the ICSI group. However, the causes remain inde-
pendent of the ICSI process itself.
In previous reports, some authors noted that chromo-
somal anomalies occurred more often in those with
severe indices, implicating the parental factor rather
than the ICSI procedure [8,24]. Bunduelle et al. [8] sug-
gested that the increased rate of aneuploidy observed
was most likely related to a higher rate of aneuploidy in
the sperm of the fathers, while Calogero et al. [25]
demonstrated that patients with abnormal sperm para-
meters had an increased aneuploidy rate that was nega-
tively correlated with sperm concentration and the
percentage of normal sperm. A normal paternal karyo-
type does not exclude the possibility of germ cell aneu-
ploidy because an altered intratesticular environment
not only damages spermatogenesis but also disrupts the
mechanisms controlling chromosomal segregation dur-
ing meiosis [25]. In support of the suggestion of male-
bearing chromosomal anomalies, we analyzed the ICSI
group according to infertility causes (i.e., male and non-
male factors). Male factors included azoospermia and
OAT, while all others were defined as non-male factors.
The ICSI group with male factors showed an approxi-
mately 1.5 times greater risk of chromosomal abnormal-
ities compared to the ICSI group with non-male factors,
indicating paternal origin of the abortuses with detected
chromosomal aberrations after ICSI. In particular,
abortuses with sex chromosomal abnormalities including
numerical and structural anomalies derived from male
factors were much more frequent than those with non-
male factors (18 vs. 11.5%).
Conclusions
We conducted a relatively large-scale study with sepa-
rate subgroups analyzed according to different etiologies
of infertility. Our results indicate that there is no risk
increased chromosomal abnormalities due to ART, with
the exception a greater number of chromosomal
abnormalities in the ICSI group with male factor inferti-
lity. Therefore, these alterations could be correlated with
the underlying parental risk of abnormalities and not
with the ICSI procedure itself.
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